Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
47 studies found for:    " May 25, 2011":" June 24, 2011"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Active, not recruiting A Randomized Controlled Trial of HIV Testing and Linkage to Care at Community Corrections
Condition: HIV
Intervention: Behavioral: Project Bridge
22 Completed
Has Results
A Study to Compare Brachial Artery Reactivity and Cardiovascular Risk of a Treatment Simplification by Darunavir/Ritonavir (DRV/r) 800/100 mg Versus a Triple Combination Therapy Containing DRV/r in HIV-1 Infected Patients
Condition: Human Immunodeficiency Virus 1
Interventions: Drug: Darunavir(DRV);   Drug: Ritonavir;   Drug: 2 nucleoside reverse transcriptase inhibitors (NRTIs)
23 Unknown  Safety of and Immune Response to a DNA HIV Vaccine Boosted With a Modified Vaccinia HIV Vaccine and Protein HIV Vaccine in Healthy Adults
Conditions: HIV Seronegativity;   HIV Preventive Vaccine
Interventions: Biological: MVA-C + gp140/MF59;   Biological: DNA-C2 + MVA-C;   Biological: DNA-C2 + MVA-C + gp140/MF59
24 Active, not recruiting HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections
Condition: Human Immunodeficiency Virus-1
Interventions: Drug: BMS-663068;   Drug: Raltegravir;   Drug: Tenofovir;   Drug: Ritonavir;   Drug: Atazanavir
25 Completed
Has Results
Multicountry, Multicenter Post-Marketing Observational Study of Clinical, Biological and Virological Outcomes, Compliance and Tolerability of Kaletra® in Routine Clinical Use
Condition: HIV-1 Patients
Intervention:
26 Completed
Has Results
Trial of Collaborative Depression Care Management for HIV Patients
Conditions: Depression;   HIV
Interventions: Other: Measurement-Based Care collaborative depression management;   Other: Enhanced Usual Care
27 Recruiting Project FIRST - Financial Incentives to Reduce Substance Use and Improve Treatment
Conditions: HIV;   Opiate Dependence
Interventions: Behavioral: Abstinence-reinforcing contingency management intervention;   Behavioral: Performance Feedback intervention
28 Completed Relative Bioavailability Study of Two New Dolutegravir/Abacavir/Lamivudine Fixed Dose Combination Tablets
Conditions: Healthy Subjects;   Infection, Human Immunodeficiency Virus
Interventions: Drug: Dolutegravir 50 mg/abacavir 600 mg/lamivudine 300 mg;   Drug: Dolutegravir 50 mg;   Drug: abacavir 600 mg/lamivudine 300 mg
29 Completed
Has Results
Treatment Perception of QD (Once a Day) Dosed Kaletra (Tablets)
Condition: Human Immunodeficiency Virus Infection
Intervention:
30 Completed Immune Response to Bivalent and Tetravalent Human Papillomavirus Vaccine in HIV Infected Adults
Conditions: HIV;   Human Papillomavirus
Interventions: Biological: Gardasil;   Biological: Cervarix
31 Active, not recruiting Naltrexone for Medication Compliance Among HIV-infected Men With Alcohol Use Disorder
Conditions: HIV;   Alcohol Use Disorder
Interventions: Drug: oral naltrexone;   Drug: Placebo pill
32 Completed Changes in Cerebral Function in Treatment Naive HIV-1 Infected Subjects Commencing Either Boosted Atazanavir With Truvada or Boosted Darunavir With Maraviroc and Kivexa
Conditions: HIV;   Impaired Cognition
Interventions: Drug: standard care;   Drug: novel treatment
33 Unknown  Trial of Safe Water Storage Among People Living With HIV
Conditions: Diarrhea;   Waterborne Disease;   HIV
Intervention: Device: Safe storage device
34 Completed Immune Response to Seasonal Influenza Vaccine in HIV Infected Individuals
Conditions: Influenza, Human;   Human Immunodeficiency Virus I Infection
Intervention:
35 Active, not recruiting HIV, Buprenorphine, and the Criminal Justice System
Conditions: Human Immunodeficiency Virus;   Acquired Immunodeficiency Syndrome;   Opiate Addiction;   Drug Dependence
Intervention: Drug: Buprenorphine/naloxone
36 Completed Pharmacokinetic and Pharmacodynamic Study of Tenofovir 1% Gel
Condition: Prevention
Intervention: Drug: Tenofovir 1% vaginal gel
37 Unknown  GePheRal: Clinical Validation of the Genotypic Diagnosis of Hiv-1 Resistance to Raltegravir by Parallel Analysis of the Genotype and Phenotype Profiles of Resistance
Conditions: HIV-1 Infected Patients;   Fold-change Resistance;   Resistance Mutations
Intervention:
38 Completed Project Power: An HIV Risk Reduction Intervention for Black Men Who Have Sex With Men and Women (BMSM/W)
Conditions: Unsafe Sex;   Risk Reduction
Interventions: Behavioral: PROJECT POWER;   Behavioral: Power Health
39 Unknown  Trial of Impact of Crime Group Intervention for Jail Inmates
Conditions: Crime;   Substance Abuse;   HIV Risk;   Criminogenic Thinking;   Shame
Intervention: Behavioral: Impact of Crime group intervention
40 Completed Home-based Exercise for Management of HIV-associated Cardiovascular Disease Risk
Conditions: Cardiovascular Diseases;   Hyperlipidemia;   Obesity
Interventions: Behavioral: Physical Activity Group;   Other: Standard Care Group

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-47) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.